Teleflex (TFX) Competitors

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 1.3% of Zimmer Biomet shares are owned by company insiders. Comparatively, 0.7% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Zimmer Biomet presently has a consensus price target of $104.42, suggesting a potential upside of 3.28%. Teleflex has a consensus price target of $152.90, suggesting a potential upside of 9.36%. Given Teleflex's stronger consensus rating and higher probable upside, analysts clearly believe Teleflex is more favorable than Zimmer Biomet.

Zimmer Biomet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Zimmer Biomet has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

Zimmer Biomet has a net margin of 9.48% compared to Teleflex's net margin of -39.67%. Zimmer Biomet's return on equity of 13.12% beat Teleflex's return on equity.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. Zimmer Biomet pays out 23.4% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Zimmer Biomet had 9 more articles in the media than Teleflex. MarketBeat recorded 20 mentions for Zimmer Biomet and 11 mentions for Teleflex. Zimmer Biomet's average media sentiment score of 1.55 beat Teleflex's score of 0.87 indicating that Zimmer Biomet is being referred to more favorably in the media.

Teleflex has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

95.6% of Teleflex shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Teleflex presently has a consensus price target of $152.90, indicating a potential upside of 9.36%. Baxter International has a consensus price target of $22.45, indicating a potential downside of 14.07%. Given Teleflex's stronger consensus rating and higher possible upside, analysts plainly believe Teleflex is more favorable than Baxter International.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays out -5.8% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Baxter International had 2 more articles in the media than Teleflex. MarketBeat recorded 13 mentions for Baxter International and 11 mentions for Teleflex. Baxter International's average media sentiment score of 1.24 beat Teleflex's score of 0.87 indicating that Baxter International is being referred to more favorably in the news media.

Baxter International has a net margin of -9.27% compared to Teleflex's net margin of -39.67%. Baxter International's return on equity of 16.57% beat Teleflex's return on equity.

Teleflex has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Penumbra has a net margin of 10.67% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Penumbra's return on equity.

Teleflex has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Teleflex currently has a consensus target price of $152.90, suggesting a potential upside of 9.36%. Penumbra has a consensus target price of $367.07, suggesting a potential upside of 14.15%. Given Penumbra's higher possible upside, analysts plainly believe Penumbra is more favorable than Teleflex.

95.6% of Teleflex shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 2.9% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Penumbra has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

In the previous week, Penumbra had 10 more articles in the media than Teleflex. MarketBeat recorded 21 mentions for Penumbra and 11 mentions for Teleflex. Penumbra's average media sentiment score of 1.58 beat Teleflex's score of 0.87 indicating that Penumbra is being referred to more favorably in the news media.

Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.2%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. Teleflex pays out -5.8% of its earnings in the form of a dividend.

In the previous week, Smith & Nephew SNATS and Smith & Nephew SNATS both had 11 articles in the media. Smith & Nephew SNATS's average media sentiment score of 1.30 beat Teleflex's score of 0.87 indicating that Smith & Nephew SNATS is being referred to more favorably in the media.

Smith & Nephew SNATS has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Smith & Nephew SNATS has higher revenue and earnings than Teleflex.

Smith & Nephew SNATS has a net margin of 0.00% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Smith & Nephew SNATS's return on equity.

Smith & Nephew SNATS currently has a consensus price target of $30.93, indicating a potential upside of 6.60%. Teleflex has a consensus price target of $152.90, indicating a potential upside of 9.36%. Given Teleflex's stronger consensus rating and higher probable upside, analysts plainly believe Teleflex is more favorable than Smith & Nephew SNATS.